BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8847599)

  • 1. Evaluation of 6,7-aziridinyl steroids and related compounds as inhibitors of aromatase (P-450arom).
    Njar VC; Grün G; Hartmann RW
    J Enzyme Inhib; 1995; 9(3):195-202. PubMed ID: 8847599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine cytochrome P450 aromatase exhibits an estrogen 2-hydroxylase activity in vitro.
    Almadhidi J; Moslemi S; Drosdowsky MA; Séralini GE
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):55-61. PubMed ID: 9009238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of thiol-containing androgens with human placental aromatase.
    Bednarski PJ; Nelson SD
    J Med Chem; 1989 Jan; 32(1):203-13. PubMed ID: 2909733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies directed toward a mechanistic evaluation of aromatase inhibition by androst-5-ene-7,17-dione. Time-dependent inactivation by the 19-nor and 5 beta, 6 beta-epoxy derivatives.
    Numazawa M; Tachibana M
    Steroids; 1997 Jul; 62(7):516-22. PubMed ID: 9253790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituted C19 steroid analogs as inhibitors of aromatase.
    Brueggemeier RW; Snider CE; Counsell RE
    Cancer Res; 1982 Aug; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 19-aza- and 19-aminoandrostenedione analogues as potential aromatase inhibitors.
    Lovett JA; Darby MV; Counsell RE
    J Med Chem; 1984 Jun; 27(6):734-40. PubMed ID: 6547488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competitive inhibition and suicide inactivation of human placental aromatase by androst-4-ene-3,6-dione derivatives and 3 alpha-methoxyandrost-4-ene-6,17-dione.
    Numazawa M; Mutsumi A; Kigawa H
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3076-80. PubMed ID: 2085891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human placental aromatase in a perfusion model. Comparison with kinetic, cell-free experiments.
    Klein H; Bartsch W; Niemand A; Stürenburg HJ; Voigt KD
    J Steroid Biochem; 1988 Feb; 29(2):161-9. PubMed ID: 3347056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 19-oxygenated derivatives of androst-4-ene-6,17-dione and androst-5-ene-4,17-dione as catalytic probes for the active site of aromatase.
    Numazawa M; Yamada K; Kidokoro K
    Biol Pharm Bull; 1999 Oct; 22(10):1134-6. PubMed ID: 10549872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies on 6-alkylandrost-4-ene-3,17-diones as aromatase inhibitors: elongation of the 6-alkyl chain.
    Numazawa M; Oshibe M
    Steroids; 1995 Aug; 60(8):506-11. PubMed ID: 8539792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androst-5-ene-7,17-dione: a novel class of suicide substrate of aromatase.
    Numazawa M; Mutsumi A; Hoshi K; Tanaka Y
    Biochem Biophys Res Commun; 1992 Jul; 186(1):32-9. PubMed ID: 1632774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3 beta-hydroxyandrost-4-en-6-one derivatives as aromatase inhibitors.
    Numazawa M; Mutsumi A; Tsuji M
    Steroids; 1989 Sep; 54(3):299-311. PubMed ID: 2588304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
    Numazawa M; Kamiyama T; Tachibana M; Oshibe M
    J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 2,2-dimethyl-4-hydroxy-4-androstene-3,17-dione as an inhibitor of aromatase.
    Furth PS; Rosenberger J; Marcotte PA; Robinson CH
    J Enzyme Inhib; 1990; 4(2):131-5. PubMed ID: 2098519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
    Numazawa M; Mutsumi A; Tachibana M
    Biochem Pharmacol; 1996 Oct; 52(8):1253-9. PubMed ID: 8937433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzymic aromatization of 6-alkyl-substituted androgens, potent competitive and mechanism-based inhibitors of aromatase.
    Numazawa M; Yoshimura A; Oshibe M
    Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):151-6. PubMed ID: 9405288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibition by 4-thiosubstituted-4-androstene-3,17-dione derivatives.
    Abul-Hajj YJ
    J Steroid Biochem; 1990 Jan; 35(1):139-43. PubMed ID: 2308324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 19-(cyclopropylamino)-androst-4-en-3,17-dione: a mechanism-based inhibitor of aromatase.
    Njar VC; Düerkop J; Hartmann RW
    J Enzyme Inhib; 1996; 10(1):47-56. PubMed ID: 8835929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of reversible inhibition of 16alpha-hydroxyandrostenedione aromatization in human placental microsomes by suicide substrates of androstenedione aromatization.
    Numazawa M; Mutsumi A; Tachibana M; Yoshimura A
    Biol Pharm Bull; 2003 Jun; 26(6):890-2. PubMed ID: 12808307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of 4-substituted-4-androstene-3,17-dione derivatives as aromatase inhibitors.
    Abul-Hajj YJ; Liu XP; Hedge M
    J Steroid Biochem Mol Biol; 1995 Aug; 54(3-4):111-9. PubMed ID: 7662584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.